During the past decade, Petz Aladar Megyei Oktato Korhaz conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 42 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 24 clinical trials were completed. i.e. 63.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Merck Sharp & Dohme LLC" with 6 trials sponsored, "Celgene" with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Petz Aladar Megyei Oktato Korhaz" are "Ulcerative Colitis" (7 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Myelofibrosis" (5 trials), "Primary Myelofibrosis" (5 trials) and "Hepatitis B" (4 trials). Many other conditions were trialed in "Petz Aladar Megyei Oktato Korhaz" in a lesser frequency.

Most popular intervention types in "Petz Aladar Megyei Oktato Korhaz" are "Drug" (103 trials), "Biological" (19 trials), "Other" (13 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "placebo" (6 trials), "Bevacizumab" (5 trials), "Etrolizumab" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Petz Aladar Megyei Oktato Korhaz" are 109 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Petz Aladar Megyei Oktato Korhaz". undefined are not yet recruiting, 19 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Petz Aladar Megyei Oktato Korhaz, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Petz Aladar Megyei Oktato Korhaz, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".

Petz Aladar Megyei Oktato Korhaz has several departments that took part in Clinical trials: "Petz Aladar Megyei Oktato Korhaz; Oncoradiologia" - 3 trials, "Petz Aladar Megyei Korhaz; Hematologia" - 6 trials, "Petz Aladar Megyei Oktató Kórház, Onkoradiológia" - 2 trials